Telesis Bio Inc (TBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 5,636 | 3,078 | 2,786 | 2,852 | 2,327 |
| Cost of Goods | 2,858 | 2,196 | 1,624 | 1,899 | 1,025 |
| Gross Profit | 2,778 | 882 | 1,162 | 953 | 1,302 |
| Operating Expenses | 16,499 | 13,175 | 11,227 | 9,424 | 7,591 |
| Operating Income | -12,863 | -12,097 | -9,441 | -7,572 | -6,264 |
| Interest Expense | 336 | 368 | 381 | 379 | 241 |
| Other Income | 11 | -22 | 2 | -1,248 | -933 |
| Pre-tax Income | -13,188 | -12,487 | -9,820 | -9,199 | -7,438 |
| Income Tax | 6 | 4 | 4 | 2 | 4 |
| Net Income Continuous | -13,194 | -12,491 | -9,824 | -9,201 | -7,442 |
| Net Income | $-13,194 | $-12,491 | $-9,824 | $-9,201 | $-7,442 |
| EPS Basic Total Ops | -8.09 | 12.41 | -6.12 | -19.06 | -25.72 |
| EPS Basic Continuous Ops | -8.09 | 12.39 | -6.04 | -19.03 | -25.77 |
| EPS Diluted Total Ops | -8.09 | 12.41 | -6.12 | -19.06 | -25.72 |
| EPS Diluted Continuous Ops | -8.09 | 12.39 | -6.04 | -19.03 | -25.77 |
| EBITDA(a) | $-12,175 | $-11,519 | $-8,968 | $-7,089 | $-5,744 |